Addex to present at the swiss equities baader conference

Geneva, switzerland, january 9, 2024 - addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that dr robert lÜtjens, head of discovery - biology, will present at the swiss equities baader conference being held in bad ragaz, switzerland, january 10-12, 2024.
ADXN Ratings Summary
ADXN Quant Ranking